Atlas Trials

Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity

Clinical trial NCT04715750 · COMPLETED

Trial details

NCT number
NCT04715750
Sponsor
Life Molecular Imaging GmbH
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer DiseaseProgressive Supranuclear Palsy
Start date
2020-11-12
Primary completion
2022-10-26
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.